By the numbers: Contract pharmacy participation in the 340B program

There are many things that set the 340B program apart from other federal prescription drug programs, namely that patients are not the primary beneficiary. While in other programs, patients qualify...
Read More
Report: More than 600 medicines in development for diseases affecting women

As we approach the end of celebrating Women’s History Month, we’re taking a closer look at the biopharmaceutical progress made and challenges to be addressed for women’s health.
Read More
The patient experience: Uncovering the barriers to care for insured Americans

Nearly half of insured Americans who take prescription medicines encounter affordability and access barriers to care, according to the findings of the newest installment of the Patient Experience...
Read More
Correcting the record: Putting medicine costs and spending in context

Last week, the Senate Finance Committee held a hearing focused on drug prices where the discussion was filled with misleading claims. We agree too many Americans struggle to afford their medicines,...
Read More
The accelerated approval pathway: Helping patients with serious or life-threatening diseases

Today, the House Energy & Commerce Committee’s Subcommittee on Health will meet to discuss policy proposals to “encourage innovation and improve oversight” regarding medical innovation. This hearing...
Read More
Sharing rebates can save Americans with diabetes $500 each year and improve adherence, especially for Black and Hispanic Americans

A new study by GlobalData looked at brand oral antidiabetic drugs (OADs) and found that sharing negotiated rebates with patients in commercial health plans at the pharmacy counter can help lower...
Read More
Biopharmaceutical industry drives economic growth in all 50 states

The innovative biopharmaceutical industry has long been a significant driver of the nation’s economic growth and a key contributor to state and regional economies. A new report from TEConomy Partners...
Read More
Guest Post: If we truly want to cure complex diseases, politicians should reject price setting

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
Veterans Affairs 101: Three charts show how the VA system differs from Medicare

The U.S. Department of Veterans Affairs (VA) primarily provides medical coverage for veterans who have experienced service-related disabilities. Its unique system was developed to meet the targeted...
Read More
If drug prices are growing below the rate of inflation, why are patients still feeling the sting at the pharmacy?

Concerns about inflation continue to be top of mind for many Americans, as prices for basic services and necessities climb at a rapid pace. But there is one bright spot in this otherwise bleak...
Read More